On the Threshold of Becoming: Technology, Artificial Intelligence, and the Next Human Evolution

Introduction

There is a question that has occupied philosophers, biologists, and futurists in equal measure: what comes next for the human species? For most of evolutionary history, the answer would have been given by the slow, undirected process of natural selection — random mutations, differential survival, incremental phenotypic change across tens of thousands of generations. Darwin's framework, refined into the twentieth-century Modern Synthesis, explained how organisms adapted to environments they did not choose. But human beings, uniquely among all species, have always been more than passive recipients of natural selection. They have been its architects.

The concept of niche construction — the capacity of organisms to modify the selective pressures of their own environments — was formally theorized by Laland et al. (2015) in a landmark paper in the Proceedings of the Royal Society B, laying the empirical and theoretical foundations for what those authors called the Extended Evolutionary Synthesis (EES). Human beings are the most prolific niche constructors in the history of life on Earth: language, agriculture, medicine, law, and education are all forms of niche construction that have fed back to shape human biology and cognition across thousands of years.

This paper examines that transformation through four disciplinary lenses — evolutionary biology, neuroscience, computational biology, and educational science — and through the ethical frameworks that must accompany any honest accounting of transformative power over human potential.

The Four Dimensions of Emergent Evolution

Theoretical Framework: Rethinking Evolution in the Age of Technology

The Extended Evolutionary Synthesis and Niche Construction

The Modern Synthesis of the early twentieth century established that evolution proceeds through natural selection acting on random genetic variation. Its explanatory power is immense, but it was developed before the sciences of epigenetics, developmental biology, and cognitive neuroscience reached their current sophistication. As those fields matured, it became apparent that the Modern Synthesis could not fully account for phenomena such as the inheritance of epigenetic marks, the role of developmental plasticity in generating novel phenotypes, or the degree to which organisms actively construct their own selective environments (Müller, 2017).

The Extended Evolutionary Synthesis addresses these limitations by incorporating what Laland et al. (2015) identify as multiple inheritance systems — genetic, epigenetic, behavioral, and ecological — and by centering niche construction as a co-equal evolutionary process alongside natural selection. In the EES, populations of organisms are not passive recipients of external selection pressures but, through various forms of niche construction, actively modify the environments that become the selective conditions for later generations.

Frontiers in Ecology and Evolution (2025) elaborates this insight by documenting how "cognitive gadgets" — culturally transmitted abilities such as language, reading, and digital information processing — are not genetically fixed but are learned inventions that, once transmitted across generations, produce structural changes in the brain and alter the selection environment for cognitive traits. The internet, AI-mediated learning, and brain-computer interfaces represent the most recent and most powerful cognitive gadgets in human history, and by the logic of the EES, they are already functioning as evolutionary forces.

Toward a Third Evolutionary Paradigm

Zou (2024), in a peer-reviewed analysis published in Medicine, Health Care and Philosophy, characterizes this moment as the emergence of "transhuman evolution" — a third evolutionary paradigm distinct from both Lamarckism and classical Darwinism, in which technological interventions in the human genome, cognition, and information environment become evolutionary forces in their own right. Unlike Lamarckian inheritance, which incorrectly posited that acquired characteristics are directly transmitted to offspring, the transhuman evolutionary paradigm is consistent with molecular biology: genetic enhancements made through CRISPR-Cas9 at the germline level genuinely would be heritable. Unlike classical Darwinism, these changes are not undirected or random — they are the product of human intention, scientific knowledge, and technological capability.

The philosophical dimensions of this shift have been engaged in the bioethics literature since Bostrom (2005) argued in Bioethics that the ethics of human enhancement technologies cannot be resolved by simply appealing to the concept of human dignity, because enhancement does not inherently diminish dignity and the concept of dignity itself may need to be extended to accommodate possible posthuman forms of flourishing.

The Genomic Dimension: CRISPR and the Rewriting of the Human Blueprint

CRISPR-Cas9: From Laboratory to Clinic

The development of the CRISPR-Cas9 gene editing system represents one of the most consequential biotechnological advances in human history. The NIH Catalyst (2025) documents the milestone that in late 2023, the United States Food and Drug Administration granted approval to Casgevy (exagamglogene autotemcel) — the first CRISPR-based therapy for clinical use — for the treatment of sickle cell disease and transfusion-dependent beta-thalassemia, with similar authorization from the European Medicines Agency in 2024.

Frontiers in Cellular Neuroscience (2025) published a comprehensive review documenting the current state of CRISPR-Cas9 applications in neurodegenerative disease, confirming that several key features of aging — including DNA damage accumulation, cellular senescence, mitochondrial dysfunction, and epigenetic alteration — are now being actively targeted using CRISPR-based tools. The review notes that while permanent CRISPR-mediated DNA editing carries significant safety considerations related to off-target effects, transient approaches including CRISPRi, CRISPRa, prime editing, and base editing offer reversible, safer alternatives advancing toward clinical deployment.

A significant 2025 advance published in Nature Communications by Breusegem et al. (2025) from the Cambridge Institute for Medical Research involved a whole-genome CRISPR microscopy screen that simultaneously assessed the impact of deleting approximately 20,000 human genes on cellular phenotypes associated with premature aging. The screen identified 43 genes capable of improving progeria cellular phenotypes, validated in a whole-organism model — a genome-scale approach made feasible by AI-assisted screening that would have been technically impossible a decade ago.

Epigenetic Reprogramming and Cellular Rejuvenation

Beyond direct genome editing, CRISPR-based tools are enabling a second class of interventions: epigenetic reprogramming. Rather than changing the DNA sequence itself, epigenetic reprogramming modifies the chemical marks on DNA and histones that regulate which genes are expressed and when. Using dCas9 — a catalytically inactive form of Cas9 that can be targeted to specific gene loci without cutting DNA — researchers are delivering epigenetic enzymes that alter chromatin state, reversing the gene-expression signatures of cellular senescence without permanently modifying the underlying genome.

Zou (2024) notes that CRISPR-Cas9 has demonstrated potential in animal models for application to human brain enhancement in the future, including a 2024 Nature study that developed a gene editing system to correct an autism-associated mutation, successfully reversing behavioral abnormalities in mice. The application of such technologies to the human germline, however, raises significant ethical concerns around informed consent, fairness, and human autonomy that remain actively contested.

The Neurotechnological Dimension: Brain-Computer Interfaces and Cognitive Expansion

From Neuroprosthetics to Cognitive Enhancement

Brain-computer interfaces (BCIs) represent a second major vector of technology-mediated human enhancement. A BCI is a system that establishes a direct communication link between the brain and external devices, allowing neural signals to be recorded, decoded, and used to control computers, robotic limbs, or other systems. Nature Electronics selected BCIs as its technology of the year in 2024, describing the field as advancing from therapeutic applications to the territory of cognitive enhancement in healthy individuals (Nature Electronics, 2024).

A 2024 peer-reviewed PMC review documents current BCI applications in treating neurological disorders including stroke, spinal cord injury, ALS, Alzheimer's disease, Parkinson's disease, depression, ADHD, and autism. The integration of AI and machine learning — including transfer learning, convolutional neural networks, and support vector machines — has substantially enhanced the precision and adaptability of these interfaces by learning from individual users' brain patterns (JMIR Biomedical Engineering, 2025).

A systematic review in BMC Geriatrics (2025) — examining 16 studies spanning 2010 to 2024 using PRISMA methodology — found that BCI-based neurofeedback training demonstrates promising results in enhancing cognitive function in older adults and those with mild cognitive impairment, with implications for extending healthy cognitive lifespan.

Non-Invasive and Invasive Frontiers

The European Council's 2024 report on brain-computer interfaces provides a comprehensive overview of the global BCI landscape, distinguishing between non-invasive systems — which record signals from the scalp without surgical intervention — and invasive systems, which implant electrodes directly into or on the brain surface. Private companies including Neuralink, BlackRock, and Kernel are advancing invasive interfaces aimed at augmenting human cognitive abilities in healthy individuals, with Neuralink having secured $687 million in funding as of 2024 (European Council, 2024).

Chen et al. (2025) document emerging frontiers including functional ultrasound BCI technology and endovascular BCIs — approaches that offer high-performance signal acquisition with substantially lower surgical risk than traditional intracortical implants. Bidirectional BCIs, which both read from and write to the brain, are identified as the next major technical frontier, with the potential to create closed-loop systems in which AI-processed neural feedback informs real-time stimulation that adapts to the user's cognitive state.

The Computational-Biological Dimension: Artificial Intelligence as a Catalyst for Scientific Discovery

AlphaFold and the Protein Structure Revolution

In 2020, Google DeepMind's AlphaFold 2 solved one of biology's most intractable problems: predicting the three-dimensional structure of a protein from its amino acid sequence alone. For fifty years, this "protein folding problem" had resisted solution; experimental methods could resolve individual protein structures, but only at enormous cost in time and resources — typically months to years per protein. AlphaFold 2 achieved accuracy comparable to experimental methods for most proteins, with a median error below one Angstrom — three times more accurate than any previous computational approach (Fang et al., 2025).

The scientific community's recognition was swift and categorical. The Nobel Prize in Chemistry for 2024 was awarded to Demis Hassabis and John Jumper of Google DeepMind for the development of AlphaFold, and to David Baker of the University of Washington for his complementary work on computational protein design — marking the first time in history that an AI-enabled scientific breakthrough received a Nobel Prize (Nature, 2024). As of 2025, the AlphaFold paper had been cited nearly 43,000 times, and the AlphaFold Protein Structure Database had been used by over 3 million researchers in more than 190 countries (Google DeepMind, 2025).

AlphaFold 3, released in May 2024, extended these capabilities to the full spectrum of biomolecular interactions — predicting how proteins interact with DNA, RNA, ligands, ions, and post-translational modifications with at least 50% improvement in accuracy for protein-molecule interactions (Fang et al., 2025). It is being deployed by Isomorphic Labs, a subsidiary of Alphabet, to accelerate pharmaceutical drug design by enabling the rapid modeling of novel drug-target interactions that were previously computationally intractable.

Accelerating the Pace of Beneficial Discovery

The evolutionary significance of AlphaFold and related AI scientific tools — including ESMFold, RFDiffusion, AlphaMissense, and AlphaProteo — lies not primarily in any single discovery but in the structural transformation of the pace at which beneficial knowledge accumulates. A peer-reviewed PMC review of AI advances in protein structure prediction for cancer drug discovery (2024) documents that AI-driven tools have compressed discovery timelines that previously required years into processes that can be completed in hours or days.

When the rate at which beneficial biological knowledge can be generated and applied to human health increases by orders of magnitude — through tools that are freely available to researchers in more than 190 countries, including over 1 million users in low- and middle-income countries — the effective cognitive and material resources available to the human species for adapting to biological challenges are enormously expanded. The 2024 Nobel Prize citation frames this as moving from understanding biological structure to designing biological function — from reading the book of life to rewriting portions of it with unprecedented intentionality (Nature, 2024).

The Cognitive-Educational Dimension: AI as a Democratizing Force for Human Potential

Personalized Learning at Scale

Education has always been a primary mechanism of niche construction — the means by which accumulated human knowledge, skills, and values are transmitted across generations to produce cognitive capabilities that could not develop through biological inheritance alone. If that transmission mechanism changes fundamentally in scale, speed, and precision, the cognitive capacities of the next generation may change in ways that are, from an evolutionary perspective, genuinely novel.

A systematic review published in ScienceDirect (2025), examining 75 peer-reviewed studies on generative AI in education, found that personalized learning was identified as a primary opportunity in 60% of studies, with expanded access and inclusion identified in 44%. A separate ScienceDirect systematic review (2025), following PRISMA 2020 methodology and examining 25 Scopus-indexed studies published between 2019 and 2024, found that AI-powered personalized learning systems enhance student engagement, motivation, and performance by providing adaptive learning pathways and tailored content.

Springer Nature's 2025 systematic review, analyzing 142 peer-reviewed empirical studies published between 2015 and 2025, finds that AI-powered adaptive learning systems enhance personalization, learner engagement, and educational equity across diverse learner populations. Arizona State University's implementation of an adaptive learning platform demonstrated measurable improvements in educational outcomes as a model for scalable AI-augmented instruction (Wiley, 2025).

Cognitive Augmentation and Its Risks

The same review literature that documents these potential benefits is equally candid about significant risks. The ScienceDirect equity review found that significant challenges accompany AI in education, including data privacy risks (56% of studies), algorithmic bias (52%), depersonalization of learning (48%), and digital divide concerns (48%).

A critical analysis published on arXiv (2025) found that frequent generative AI usage shows a negative correlation with critical thinking abilities, with cognitive offloading acting as a mediating factor, and that ChatGPT promotes metacognitive laziness in learners who become dependent on AI assistance. These findings underscore that the cognitive evolution enabled by AI tools depends critically on how those tools are designed, implemented, and governed.

Ethical Dimensions: Equity, Access, Consent, and the Governance of Human Enhancement

The Stratification Risk

The most urgent ethical challenge posed by these technologies is the risk of stratification — of a division between those who have access to genetic enhancement, cognitive augmentation, and AI-accelerated education, and those who do not. Bostrom (2005), writing in Bioethics, identifies this tension at the foundation of transhumanist ethics: if enhancement technologies confer substantial advantages, the question of who has access to them is not merely a matter of distributive justice but of species-level bifurcation. Bostrom argues that the bioconservative response — restricting or banning enhancement technologies — is itself potentially unjust, insofar as it denies ordinary people the possibility of transcending suffering and limitation. This reframes the problem as one of equitable distribution rather than prohibition.

The European Council's 2024 BCI report raises consent and reversibility as central bioethical concerns specifically for neural technologies. The report notes that both invasive and non-invasive BCI techniques raise concerns about reversibility — particularly for implanted systems, where technological obsolescence may necessitate hardware upgrades inside the human body, and where the long-term neurological effects of chronic implants remain incompletely understood.

Access and the Democratic Imperative

The democratizing potential of AI-mediated education provides one counterweight to the stratification concern. AlphaFold's free database being used by over 1 million researchers in low- and middle-income countries, and AI tutoring systems deployed globally, suggest that at least some forms of AI-augmented human capability may be accessible to a much broader population than genetic enhancement or neural implants.

Wiley's (2025) systematic analysis frames this as directly relevant to United Nations Sustainable Development Goal 4 (Quality Education) and SDG 8 (Decent Work and Economic Growth). The ScienceDirect equity review (2025) is clear, however, that equity will not emerge automatically from generative AI adoption — it must be intentionally designed, implemented, and monitored. This conclusion applies with equal force to CRISPR and BCI governance: these technologies do not inherently democratize or stratify — they amplify the choices that institutions and societies make about who receives benefits and who bears costs.

Discussion: An Integrated Analysis of the Emergent Evolutionary Moment

Considered together across the four dimensions examined, these technologies describe a coherent and mutually reinforcing transformation of the human niche. This transformation shares several features that distinguish it from all previous episodes of human niche construction.

First, the speed of this transformation is categorically different from anything that preceded it. CRISPR-Cas9 went from discovery in bacterial immune systems to FDA-approved clinical therapy in less than a decade. AlphaFold went from a novel machine learning approach in 2018 to a Nobel Prize and a database of 200 million protein structures in seven years.

Second, the intentionality of this transformation is unprecedented. Previous episodes of niche construction — the development of agriculture, the invention of writing, the industrial revolution — were cumulative and emergent rather than designed. The current technologies, by contrast, are being developed by researchers who explicitly understand their evolutionary implications.

Third, the potential benefits of this transformation, if equitably distributed, are genuinely profound for human welfare. CRISPR research could meaningfully address Alzheimer's, Parkinson's, ALS, and Huntington's disease. BCI systems are restoring communication to individuals with locked-in syndrome. AlphaFold is making structural biology accessible to researchers at universities in low-income countries. AI-personalized learning is enabling students who would previously have been underserved by standardized instruction to access individualized educational support.

Fourth, the risks are proportional to the ambition. A genomic intervention that reduces a devastating neurodegenerative disease in one generation could, if extended to the germline without adequate safety data, introduce unforeseen heritable changes in the next. Each vector of advancement described in this paper carries a corresponding vector of risk that requires governance frameworks of commensurate sophistication.

Conclusion

This paper has argued, across four disciplinary dimensions and through a rigorous theoretical framework grounded in the Extended Evolutionary Synthesis, that the next human evolution is not merely approaching — it has begun. It is being driven not by the blind forces of natural selection operating across geological time, but by the intentional, technology-mediated construction of new biological, neural, computational, and cognitive niches that are already reshaping what human beings can do, know, and become.

The genomic dimension is manifested in FDA-approved CRISPR therapies and genome-scale screening techniques from Cambridge identifying 43 genes capable of rescuing premature aging phenotypes. The neurotechnological dimension is manifested in BCIs that restore speech and motor function. The computational-biological dimension is manifested in AlphaFold — the Nobel Prize-winning AI system that collapsed fifty years of unresolved protein-structure prediction into a free, globally accessible tool. The cognitive-educational dimension is manifested in AI-adaptive learning systems documented across 142 peer-reviewed studies to enhance engagement, personalization, and educational equity.

The ethical imperative that emerges from this analysis is not a choice between embracing or rejecting these technologies. That choice has already been made, by markets, governments, research institutions, and individual patients and learners worldwide. The imperative is to govern them — to design the policies, access frameworks, safety protocols, and consent structures that determine whether this transformation narrows or deepens existing human inequalities.

References

• BMC Geriatrics. (2025). Brain computer interfaces for cognitive enhancement in older people: Challenges and applications: A systematic review. Springer Nature. https://link.springer.com/article/10.1186/s12877-025-05676-4
• Bostrom, N. (2005). In defense of posthuman dignity. Bioethics, 19(3), 202–214. https://doi.org/10.1111/j.1467-8519.2005.00437.x
• Breusegem, S. Y., Houghton, J., Romero-Bueno, R., Fragoso-Luna, A., Kentistou, K. A., Ong, K. K., Janssen, A. F. J., Bright, N. A., Riedel, C. G., Perry, J. R. B., Askjaer, P., & Larrieu, D. (2025). A multiparametric anti-aging CRISPR screen uncovers a role for BAF in protein synthesis regulation. Nature Communications, 16, 1681. https://doi.org/10.1038/s41467-025-56916-5
• Chen, S., Chen, M., Wang, X., Liu, X., Liu, B., & Ming, D. (2025). Brain–computer interfaces in 2023–2024. Brain-X. https://onlinelibrary.wiley.com/doi/full/10.1002/brx2.70024
• European Council. (2024). From vision to reality: Promises and risks of brain-computer interfaces. Council of the European Union. https://www.consilium.europa.eu/media/fh4fw3fn/art_braincomputerinterfaces_2024_web.pdf
• Fang, Z., Ran, H., Zhang, Y., Chen, C., Lin, P., Zhang, X., & Wu, M. (2025). AlphaFold 3: An unprecedented opportunity for fundamental research and drug development. Precision Clinical Medicine, 8(3), pbaf015. https://doi.org/10.1093/pcmedi/pbaf015
• Frontiers in Cellular Neuroscience. (2025). CRISPR-Cas9: Bridging the gap between aging mechanisms and therapeutic advances in neurodegenerative disorders. https://doi.org/10.3389/fncel.2025.1681891
• Frontiers in Ecology and Evolution. (2025). Postmodern evolutionary framework for chronic diseases: Cultural evolution allows multicausal explanations. https://doi.org/10.3389/fevo.2025.1608810
• Frontiers in Systems Neuroscience. (2021). Progress in brain-computer interface: Challenges and opportunities. https://doi.org/10.3389/fnsys.2021.578875
• Google DeepMind. (2025). AlphaFold: Five years of impact. https://deepmind.google/blog/alphafold-five-years-of-impact/
• JMIR Biomedical Engineering. (2025). Advancing brain-computer interface closed-loop systems for neurorehabilitation. https://biomedeng.jmir.org/2025/1/e72218
• Laland, K. N., Uller, T., Feldman, M. W., Sterelny, K., Müller, G. B., Moczek, A., Odling-Smee, J., & Wray, G. A. (2015). The extended evolutionary synthesis: Its structure, assumptions and predictions. Proceedings of the Royal Society B, 282, 20151019. https://doi.org/10.1098/rspb.2015.1019
• Müller, G. B. (2017). Why an extended evolutionary synthesis is necessary. Interface Focus, 7(5), 20170015. https://doi.org/10.1098/rsfs.2017.0015
• National Institutes of Health. (2025). What's cooking with CRISPR? NIH Catalyst, 33(1). https://irp.nih.gov/...
• Nature. (2024). Chemistry Nobel goes to developers of AlphaFold AI that predicts protein structures. https://www.nature.com/articles/d41586-024-03214-7
• Nature Electronics. (2024). An update for brain–computer interfaces. 7, 725. https://doi.org/10.1038/s41928-024-01257-2
• PubMed Central. (2024). Brain–computer interfaces: The innovative key to unlocking neurological conditions. https://pmc.ncbi.nlm.nih.gov/articles/PMC11392146/
• PubMed Central. (2024). Advances in AI for protein structure prediction: Implications for cancer drug discovery and development. https://pmc.ncbi.nlm.nih.gov/articles/PMC10968151/
• ScienceDirect. (2025a). Generative AI to bridge the educational divide: Personalized learning and challenges. https://www.sciencedirect.com/...
• ScienceDirect. (2025b). Artificial intelligence in personalized learning: A global systematic review. https://www.sciencedirect.com/...
• Springer Nature. (2025). Artificial intelligence in adaptive education: A systematic review of techniques for personalized learning. Discover Education. https://doi.org/10.1007/s44217-025-00908-6
• Wiley Online Library. (2025). AI-driven adaptive learning for sustainable educational transformation. Sustainable Development. https://doi.org/10.1002/sd.3221
• Zhao, J. (2025). Brain-computer interface: A revolutionary technology expanding the frontiers of the human brain and the future of neurosurgery. Medical Journal of Peking Union Medical College Hospital, 16(2), 269–276. https://doi.org/10.12290/xhyxzz.2025-0152
• Zou, Y. (2024). Genetic enhancement from the perspective of transhumanism: Exploring a new paradigm of transhuman evolution. Medicine, Health Care and Philosophy, 27(4), 529–544. https://doi.org/10.1007/s11019-024-10224-9